A Study to Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)

NCT04282590 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped due to COVID-19 pandemic

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG: TRK-750/Placebo
DRUG: Placebo/TRK-750

Sponsor

Toray Industries, Inc